Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors - PubMed (original) (raw)
Comparative Study
. 2002 Oct;16(12):1575-83.
doi: 10.1096/fj.02-0319com.
Affiliations
- PMID: 12374780
- DOI: 10.1096/fj.02-0319com
Comparative Study
Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors
Renhai Cao et al. FASEB J. 2002 Oct.
Abstract
A newly discovered PDGF isoform, PDGF-CC, is expressed in actively angiogenic tissues such as placenta, some embryonic tissues, and tumors. We test the possibility that PDGF-CC promotes angiogenesis in vivo. The core domain (mature form) of human PDGF-CC is sufficiently potent to stimulate neovascularization in the mouse cornea. The corneal angiogenic response induced by PDGF-CC is robust although the area of neovascularization is smaller than those of FGF-2- and VEGF-stimulated angiogenesis. Similarly, PDGF-BB and PDGF-AB induce angiogenic responses virtually indistinguishable from PDGF-CC-stimulated vessels. In contrast, PDGF-AA displays only a weak angiogenic response in the mouse cornea. Although there was no significant difference in incorporation of mural cells to the newly formed blood vessels induced by PDGF-BB and -CC, the percentage of mural cell positive vessels induced by PDGF-AA was greater than those induced by FGF-2, PDGF-BB, and PDGF-CC. In the developing chick embryo, PDGF-CC induced branch sprouts from established blood vessels. In PDGF receptor-transfected endothelial cells, PDGF-CC activated the PDGF receptor alpha subunit (PDGFR-alpha). PDGF-CC, but not PDGF-AA, was able to activate PDGFR-beta receptor in endothelial cells that coexpress both alpha and beta forms of receptors. Thus, the PDGF-CC-mediated angiogenic response is most likely transduced by PDGF-alphaalpha and -alphabeta receptors. These data demonstrate that the PDGF family is a complex and important group of proangiogenic factors.
Similar articles
- Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability.
Zhang J, Cao R, Zhang Y, Jia T, Cao Y, Wahlberg E. Zhang J, et al. FASEB J. 2009 Jan;23(1):153-63. doi: 10.1096/fj.08-113860. Epub 2008 Sep 30. FASEB J. 2009. PMID: 18827023 - The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG. Zymek P, et al. J Am Coll Cardiol. 2006 Dec 5;48(11):2315-23. doi: 10.1016/j.jacc.2006.07.060. Epub 2006 Nov 13. J Am Coll Cardiol. 2006. PMID: 17161265 - PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F. Wood JM, et al. Cancer Res. 2000 Apr 15;60(8):2178-89. Cancer Res. 2000. PMID: 10786682 - Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S. Shibuya M, et al. Princess Takamatsu Symp. 1994;24:162-70. Princess Takamatsu Symp. 1994. PMID: 8983073 Review. - The platelet-derived growth factor system in renal disease: an emerging role of endogenous inhibitors.
van Roeyen CR, Ostendorf T, Floege J. van Roeyen CR, et al. Eur J Cell Biol. 2012 Jun-Jul;91(6-7):542-51. doi: 10.1016/j.ejcb.2011.07.003. Epub 2011 Aug 27. Eur J Cell Biol. 2012. PMID: 21872965 Review.
Cited by
- Development and validation of an automated high-throughput system for zebrafish in vivo screenings.
Letamendia A, Quevedo C, Ibarbia I, Virto JM, Holgado O, Diez M, Izpisua Belmonte JC, Callol-Massot C. Letamendia A, et al. PLoS One. 2012;7(5):e36690. doi: 10.1371/journal.pone.0036690. Epub 2012 May 15. PLoS One. 2012. PMID: 22615792 Free PMC article. - PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently.
Zheng L, Zhao C, Du Y, Lin X, Jiang Y, Lee C, Tian G, Mi J, Li X, Chen Q, Ye Z, Huang L, Wang S, Ren X, Xing L, Chen W, Huang D, Gao Z, Zhang S, Lu W, Tang Z, Wang B, Ju R, Li X. Zheng L, et al. Oncotarget. 2016 Nov 22;7(47):77902-77915. doi: 10.18632/oncotarget.12843. Oncotarget. 2016. PMID: 27788490 Free PMC article. - Cerebrovascular development: mechanisms and experimental approaches.
Chico TJA, Kugler EC. Chico TJA, et al. Cell Mol Life Sci. 2021 May;78(9):4377-4398. doi: 10.1007/s00018-021-03790-1. Epub 2021 Mar 10. Cell Mol Life Sci. 2021. PMID: 33688979 Free PMC article. Review. - Pericyte-fibroblast transition promotes tumor growth and metastasis.
Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, Hartman J, Religa P, Morikawa H, Ishii Y, Sasahara M, Larsson O, Cossu G, Cao R, Lim S, Cao Y. Hosaka K, et al. Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5618-27. doi: 10.1073/pnas.1608384113. Epub 2016 Sep 7. Proc Natl Acad Sci U S A. 2016. PMID: 27608497 Free PMC article. - Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system.
Das S, Singh G, Baker AB. Das S, et al. Biomaterials. 2014 Jan;35(1):196-205. doi: 10.1016/j.biomaterials.2013.09.105. Epub 2013 Oct 16. Biomaterials. 2014. PMID: 24138828 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous